Evidence map›Paper›PMID 29157365›Full record

ReviewOphthalmology2017

The Future of Imaging in Detecting Glaucoma Progression.

Fabio Lavinsky, Gadi Wollstein, Jenna Tauber, Joel S Schuman

Abstract readReview
In one paragraph

Review in Ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fabio LavinskyNYU Langone Eye Center, New York University School of Medicine, New York, New York.
Gadi WollsteinNYU Langone Eye Center, New York University School of Medicine, New York, New York.
Jenna TauberNYU Langone Eye Center, New York University School of Medicine, New York, New York.
Joel S SchumanNYU Langone Eye Center, New York University School of Medicine, New York, New York. Electronic address: Joel.Schuman@med.nyu.edu.

Funding

Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1R01EY013178 · NEI · WILLS EYE HEALTH SYSTEM · PI Joel S Schuman · 2000 to 2026
$17.5M
Advanced Imaging for GlaucomaR01EY013516 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HUANG, DAVID · 2003 to 2012
$15.9M
Novel Optical Diagnostics with Optical Coherence TomographyR01EY011289 · NEI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JAMES G FUJIMOTO · 1995 to 2026
$9.5M
Functional and Structural Optical Coherence Tomography for GlaucomaR01EY023285 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI David Huang · 2013 to 2026
$8.8M
NEI NIH HHS R01 EY011289NEI NIH HHS R01 EY013178NEI NIH HHS R01 EY013516NEI NIH HHS R01 EY023285
6 · The paper itself

Abstract

Ocular imaging has been heavily incorporated into glaucoma management and provides important information that aids in the detection of disease progression. Longitudinal studies have shown that the circumpapillary retinal nerve fiber layer is an important parameter for glaucoma progression detection, whereas other studies have demonstrated that macular parameters, such as the ganglion cell inner plexiform layer and optic nerve head parameters, also are useful for progression detection. The introduction of novel technologies with faster scan speeds, wider scanning fields, higher resolution, and improved tissue penetration has enabled the precise quantification of additional key ocular structures, such as the individual retinal layers, optic nerve head, choroid, and lamina cribrosa. Furthermore, extracting functional information from scans such as blood flow rate and oxygen consumption provides new perspectives on the disease and its progression. These novel methods promise improved detection of glaucoma progression and better insight into the mechanisms of progression that will lead to better targeted treatment options to prevent visual damage and blindness.

Indexed as

Diagnostic ImagingDiagnostic Techniques, OphthalmologicalDisease ProgressionGlaucoma, Open-AngleHumansNerve FibersOptic Nerve DiseasesRetinal Ganglion Cells

Identifiers

PMID29157365
PMCPMC5777232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.